JP2024514477A5 - - Google Patents
Info
- Publication number
- JP2024514477A5 JP2024514477A5 JP2023560004A JP2023560004A JP2024514477A5 JP 2024514477 A5 JP2024514477 A5 JP 2024514477A5 JP 2023560004 A JP2023560004 A JP 2023560004A JP 2023560004 A JP2023560004 A JP 2023560004A JP 2024514477 A5 JP2024514477 A5 JP 2024514477A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- tcr
- amino acid
- acid sequence
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163167433P | 2021-03-29 | 2021-03-29 | |
| US63/167,433 | 2021-03-29 | ||
| US202163210198P | 2021-06-14 | 2021-06-14 | |
| US63/210,198 | 2021-06-14 | ||
| US202263314870P | 2022-02-28 | 2022-02-28 | |
| US63/314,870 | 2022-02-28 | ||
| PCT/US2022/022324 WO2022212361A1 (en) | 2021-03-29 | 2022-03-29 | Peptides and engineered t cell receptors targeting sars-cov-2 antigens and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024514477A JP2024514477A (ja) | 2024-04-02 |
| JP2024514477A5 true JP2024514477A5 (https=) | 2025-04-07 |
Family
ID=83456819
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023560004A Pending JP2024514477A (ja) | 2021-03-29 | 2022-03-29 | Ｓａｒｓ－ｃｏｖ－２抗原を標的とするペプチドおよび操作されたｔ細胞受容体ならびに使用の方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240293459A1 (https=) |
| EP (1) | EP4313139A4 (https=) |
| JP (1) | JP2024514477A (https=) |
| KR (1) | KR20240005714A (https=) |
| AU (1) | AU2022246811A1 (https=) |
| WO (1) | WO2022212361A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024243227A2 (en) * | 2023-05-22 | 2024-11-28 | Board Of Regents, The University Of Texas System | Peptides and engineered t cell receptors targeting brachyury antigen and methods of use |
| KR20250115147A (ko) | 2024-01-23 | 2025-07-30 | 국립경국대학교 산학협력단 | 재조합 ＳＡＲＳＣｏＶ２ 렌티바이러스 벡터를 이용한 ＳＡＲＳＣｏＶ２ 자가면역 백신의 제조방법 |
| WO2026019786A1 (en) * | 2024-07-16 | 2026-01-22 | Board Of Regents, The University Of Texas System | Peptides and engineered t cell receptors targeting brachyury antigen and methods of use |
| WO2026018922A1 (ja) * | 2024-07-19 | 2026-01-22 | 国立大学法人京都大学 | ＳＡＲＳ－ＣｏＶ－２感染症治療および／または予防用細胞及びその製法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004110349A2 (en) * | 2003-05-14 | 2004-12-23 | Siga Technologies, Inc. | Sars t cell epitopes and methods for identifying same |
| US20210147550A1 (en) * | 2017-08-18 | 2021-05-20 | Joshua Michael Francis | Antigen-binding proteins targeting shared antigens |
| EP3731876A4 (en) * | 2017-12-28 | 2022-04-06 | Gritstone bio, Inc. | ANTIGEN-BINDING PROTEINS TARGETING SHARED ANTIGENS |
| WO2024227034A1 (en) * | 2023-04-27 | 2024-10-31 | Serum Detect, Inc. | T-cell receptor signatures indicative of early stages of cancer |
-
2022
- 2022-03-29 KR KR1020237037284A patent/KR20240005714A/ko active Pending
- 2022-03-29 AU AU2022246811A patent/AU2022246811A1/en active Pending
- 2022-03-29 US US18/552,417 patent/US20240293459A1/en active Pending
- 2022-03-29 JP JP2023560004A patent/JP2024514477A/ja active Pending
- 2022-03-29 EP EP22782016.4A patent/EP4313139A4/en active Pending
- 2022-03-29 WO PCT/US2022/022324 patent/WO2022212361A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024514477A5 (https=) | ||
| JP2022050400A5 (https=) | ||
| JP2020517287A5 (https=) | ||
| JP2020186248A5 (https=) | ||
| JP2021533779A5 (https=) | ||
| JP2024063213A5 (https=) | ||
| JP2023527049A5 (https=) | ||
| JP2021521781A5 (https=) | ||
| JP2025090743A5 (https=) | ||
| JP2019522465A5 (https=) | ||
| JP2018502572A5 (https=) | ||
| JP2020521452A5 (https=) | ||
| JP2020500510A5 (https=) | ||
| JP2021514618A5 (https=) | ||
| JP2020530762A5 (https=) | ||
| JP2021510162A5 (https=) | ||
| HRP20220080T1 (hr) | Poboljšane imunoglobulinske varijabilne domene koje vežu serumski albumin | |
| JP2019533441A5 (https=) | ||
| JP2018171063A5 (https=) | ||
| JP2022523524A5 (https=) | ||
| JP2020505919A5 (https=) | ||
| CO6150201A2 (es) | Anticuerpo humanizado contra beta amiloide | |
| JP2021512159A5 (https=) | ||
| JP2022512234A5 (https=) | ||
| JP2020524661A5 (https=) |